, Volume 47, Issue 3, pp 405–424 | Cite as

Omega-3 Fatty Acids

Current Status in Cardiovascular Medicine
  • Erik Berg Schmidt
  • Jørn Dyerberg
Review Article


Omega-3 polyunsaturated fatty acids (PUFA) reduce fasting and postprandial triglycerides, decrease platelet and leucocyte reactivity, and may slightly decrease blood pressure. Omega-3 PUFA may also beneficially influence vessel wall characteristics and blood rheology. Furthermore, these compounds have been shown to inhibit ventricular tachyarrhythmias in animals. Omega-3 PUFA may impair fibrinolysis and could lead to increased oxidation of lipoproteins. Potential adverse effects must not be neglected, but should be viewed in light of the beneficial effects of these agents.

Clinical studies investigating the effects of dietary omega-3 PUFA in the prevention and treatment of cardiovascular disease (CVD) are beginning to emerge. The results have offered some promise, but further studies are needed to define the role of these agents in CVD.

Long term trials and studies using omega-3 PUFA as adjuvants to conventional therapy in patients with coronary artery disease, hyperlipidaemia and hypertension may be of particular interest.


Fish Consumption High Density Lipoprotein Platelet Reactivity High Density Lipoprotein Cholesterol High Density Lipoprotein Cholesterol Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackman RG. Concerns for utilization of marine lipids and oils. Food Technology 42: 151–155, 1988Google Scholar
  2. Annuzzi G, Rivellese A, Capaldo B, et al. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in noninsulin-dependent diabetic patients. Atherosclerosis 87: 65–73, 1991PubMedCrossRefGoogle Scholar
  3. Appel LJ, Miller ER, Seidler AJ, et al. Does supplementation of diet with fish oil reduce blood pressure?. Archives of Internal Medicine 153: 1429–1438, 1993PubMedCrossRefGoogle Scholar
  4. Aursnes I, Dørum H-P, Smith P, et al. Low and high risk coronary patients discriminated by blood platelet fatty acid composition. Scandinavian Journal of Clinical and Laboratory Investigation 46: 115–120, 1986PubMedCrossRefGoogle Scholar
  5. Austin MA. Plasma triglycérides and coronary heart disease. Arteriosclerosis 11: 2–14, 1991CrossRefGoogle Scholar
  6. Bach R, Schmidt U, Jung F, et al. Effects of fish oil capsules in two dosages on blood pressure, platelet functions, haemorheological and clinical chemistry parameters in apparently healthy subjects. Annals of Nutrition and Metabolism 33: 359–367, 1989PubMedCrossRefGoogle Scholar
  7. Bagdade JD, Buchanan WE, Levy RA, et al. Effects of ω-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM. Diabetes 39: 426–431, 1990PubMedCrossRefGoogle Scholar
  8. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial offish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 85: 950–956, 1992PubMedCrossRefGoogle Scholar
  9. Bang HO, Dyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic West coast Eskimos. Lancet 1: 1143–1146, 1971PubMedCrossRefGoogle Scholar
  10. Bang HO, Dyerberg J, Sinclair HM. The composition of Eskimo food in North-Western Greenland. American Journal of Clinical Nutrition 33: 2657–2661, 1980PubMedGoogle Scholar
  11. Barbir M, Hunt B, Kushwaha S, et al. Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients. American Journal of Cardiology 70: 1596–1601, 1992PubMedCrossRefGoogle Scholar
  12. Barcelli U, Glas-Greenwalt P, Pollak VE. Enhancing effect of dietary supplementation with ω-3 fatty acids on plasma fibrinolysis in normal subjects. Thrombosis Research 39: 307–312, 1985PubMedCrossRefGoogle Scholar
  13. Bertomeu MC, Crozier GL, Haas TA, et al. Selective effects of dietary fats on vascular 13-HODE synthesis and platelet/vessel wall interactions. Thrombosis Research 59: 819–830, 1990PubMedCrossRefGoogle Scholar
  14. Bertrand E, Cloitre B, Ticolat R, et al. Platelet aggregability and fibrinolysis in 50 Ivorans and 50 Europeans all living in Abadjan: role of fish consumption. Nouvelle Revue Francaise d’Hematologie 29: 237–245, 1987PubMedGoogle Scholar
  15. Bierman EL. Atherogenesis in diabetes. Arteriosclerosis and Thrombosis 12: 647–656, 1992PubMedCrossRefGoogle Scholar
  16. Bjerregaard P, Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. International Journal of Epidemiology 17: 514–519, 1988PubMedCrossRefGoogle Scholar
  17. Blonk MC, Bilo HJG, Nauta JJP, et al. Dose-response effects of fish oil supplementation in healthy volunteers. American Journal of Clinical Nutrition 52: 120–127, 1990PubMedGoogle Scholar
  18. Boberg M, Pollare T, Siegbahn A, et al. Supplementation with n-3 fatty acids reduces triglycérides but increases PAI-1 in non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation 22: 645–650, 1992PubMedCrossRefGoogle Scholar
  19. Bönaa K, Bjerve KS, Nordöy A. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans. Arteriosclerosis and Thrombosis 12: 675–681, 1992bPubMedCrossRefGoogle Scholar
  20. Bönaa KH, Bjerve KS, Nordöy A. Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: the Tromsö Study. American Journal of Clinical Nutrition 55: 1126–1134, 1992aPubMedGoogle Scholar
  21. Bönaa KH, Bjerve KS, Straume B, et al. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. New England Journal of Medicine 322: 795–801, 1990PubMedCrossRefGoogle Scholar
  22. Borkman M, Chisholm DJ, Furier SM, et al. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38: 1314–1319, 1989PubMedCrossRefGoogle Scholar
  23. Brown AJ, Roberts DCK. Moderate fish oil intake improves lipemic response to a standard fat meal. Arteriosclerosis and Thrombosis 11: 457–466, 1991PubMedCrossRefGoogle Scholar
  24. Bulliyya G, Reddy KK, Reddy GPR, et al. Lipid profiles among fish-consuming coastal and non-fish-consuming inland populations. European Journal of Clinical Nutrition 44: 481–485, 1990PubMedGoogle Scholar
  25. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2: 757–761, 1989PubMedCrossRefGoogle Scholar
  26. Charnock JS. Antiarrhythmic effects of fish oils. World Review of Nutrition and Dietetics 66: 278–291, 1991PubMedGoogle Scholar
  27. Chin JPF, Gust AP, Nestel PJ, et al. Marine oil dose-dependently inhibits vasoconstriction of forearm resistance vessels in humans. Hypertension 21: 22–28, 1993PubMedCrossRefGoogle Scholar
  28. Christensen JH, Gustenhoff P, Ejlersen E, et al. The effect of n-3 polyunsaturated fatty acids on cardiac ventricular arrhythmias — a pilot study. In De Caterina et al. (Eds) n-3 fatty acids and vascular disease, pp. 151–157, Springer-Verlag, Berlin, 1993Google Scholar
  29. Cobiac L, Clifton PM, Abbey M, et al. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males. American Journal of Clinical Nutrition 53: 1210–1216, 1991PubMedGoogle Scholar
  30. Colwell JA, Franz MJ, Ginsberg H, et al. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 12: 573–579, 1989Google Scholar
  31. Cortellaro M, Borschetti C, Cofrancesco E, et al. The PLAT study: a multidisciplinary study of hemostatic function and conventional risk factors in cardiovascular disease patients. Atherosclerosis 90: 109–118, 1991PubMedCrossRefGoogle Scholar
  32. Crombie IK, McLoone P, Smith WCS, et al. International differences in coronary heart disease mortality and consumption of fish and other foodstuffs. European Heart Journal 8: 560–563, 1987PubMedGoogle Scholar
  33. Culp BR, Lands WEM, Lucchesi BR, et al. The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins 20: 1021–1031, 1980PubMedGoogle Scholar
  34. Curb JD, Reed DM. Fish consumption and coronary heart disease. New England Journal of Medicine 313: 821, 1985Google Scholar
  35. Dallongeville J, Boulet L, Davignon J, et al. Fish oil supplementation reduces β-very low density lipoprotein in type III dysbetalipoproteinemia. Arteriosclerosis and Thrombosis 11: 864–871, 1991PubMedCrossRefGoogle Scholar
  36. Dallongeville J, Selinger E, Davignon J, et al. Fish oil supplementation reduces Lp (a) concentrations in type III dysbetalipoproteinemia. Clinical Chemistry 38: 1510–1511, 1992PubMedGoogle Scholar
  37. Davidson MH, Burns JH, Subbaiah PV, et al. Marine oil capsule therapy for the treatment of hyperlipidemia. Archives of Internal Medicine 151: 1732–1740, 1991PubMedCrossRefGoogle Scholar
  38. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. British Heart Journal 69: 377–381, 1993PubMedCrossRefGoogle Scholar
  39. Davis HR, Bridenstine RT, Vesselinovitch D, et al. Fish oil inhibits development of atherosclerosis in rhesus monkeys. Arteriosclerosis 7: 441–449, 1987PubMedCrossRefGoogle Scholar
  40. De Caterina R, Giannessi D, Mazzone A, et al. Vascular prostacyclin is increased in patients ingesting ω-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation 82: 428–438, 1990CrossRefGoogle Scholar
  41. Dehmer GJ, Popma JJ, Van Den Berg EK, et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. New England Journal of Medicine 319: 733–740, 1988PubMedCrossRefGoogle Scholar
  42. de Knijff P, Johansen LG, Rosseneu M, et al. Lipoprotein profile of a Greenland Inuit population. Arteriosclerosis and Thrombosis 12: 1371–1379, 1992PubMedCrossRefGoogle Scholar
  43. Dolecek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Review of Nutrition and Dietetics 66: 205–216, 1991PubMedGoogle Scholar
  44. Drevon CA, Rustan AC. The effect of n-3 fatty acids on lipid and lipoprotein metabolism. In De Caterina et al. (Eds) n-3 fatty acids and vascular disease, pp. 51–57, Springer-Verlag, Berlin, 1993Google Scholar
  45. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2: 433–435, 1979PubMedCrossRefGoogle Scholar
  46. Dyerberg J, Bang HO, Stoffersen E, et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet 2: 117–119, 1978PubMedCrossRefGoogle Scholar
  47. Emeis JJ, van Houwelingen AC, van den Hoogen CM, et al. A moderate fish intake increases Plasminogen activator inhibitor type-1 in healthy volunteers. Blood 74: 233–237, 1989PubMedGoogle Scholar
  48. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New England Journal of Medicine 320: 265–271, 1989PubMedCrossRefGoogle Scholar
  49. Ernst E. Effects of n-3 fatty acids on blood rheology. Journal of Internal Medicine 225 (Suppl. 1.): 129–132, 1989Google Scholar
  50. Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 100: 1–12, 1993PubMedCrossRefGoogle Scholar
  51. Failor RA, Childs MT, Bierman EL. The effects of ω3 and ω fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia. Metabolism 37: 1021–1028, 1988PubMedCrossRefGoogle Scholar
  52. Fasching P, Ratheiser K, Waldhausl W, et al. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 40: 583–589, 1991PubMedCrossRefGoogle Scholar
  53. Feskens EJM, Bowles CH, Kromhout D. Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14: 935–941, 1991PubMedCrossRefGoogle Scholar
  54. Feskens EJM, Bowles CH, Kromhout D. Association between fish intake and coronary heart disease mortality. Diabetes Care 16: 1029–1034, 1993PubMedCrossRefGoogle Scholar
  55. Finchham JE, Gouws E, Woodroof CW Atherosclerosis: chronic effects of fish oil and a therapeutic diet in nonhuman primates. Arteriosclerosis and Thrombosis 11: 719–732, 1991CrossRefGoogle Scholar
  56. Fischer S, Vischer A, Preac-Mursic V, et al. Dietary docosahexaenoic acid is retroconverted in man to eicosapentaenoic acid which can be quickly transformed to Prostaglandin I3. Prostaglandins 34: 367–375, 1987PubMedGoogle Scholar
  57. Fischer S, Weber PC, Dyerberg J. The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos. Prostaglandins 32: 235–241, 1986PubMedGoogle Scholar
  58. Fisher M, Levine PH, Weiner BH, et al. Dietary n-3 fatty acid supplementation reduces Superoxide production and chemilumines-cence in a monocyte-enriched preparation of leukocytes. American Journal of Clinical Nutrition 51: 804–808, 1990PubMedGoogle Scholar
  59. Fisher M, Upchurch KS, Levine PH, et al. Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation 10: 387–392, 1986PubMedCrossRefGoogle Scholar
  60. Fleischhauer FJ, Yan W-D, Fischeil TA. Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients. Journal of the American College of Cardiology 21: 982–989, 1993PubMedCrossRefGoogle Scholar
  61. Force T, Malis CD, Guerrero JL, et al. n-3 fatty acids increase postischemic blood flow but do not reduce myocardial necrosis. American Journal of Physiology 257: H1204–H1210, 1989PubMedGoogle Scholar
  62. Force T, Milani R, Hibberd P, et al. Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Circulation 84: 2286–2293, 1991PubMedCrossRefGoogle Scholar
  63. Fox PL, DiCorleto PE. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 241: 453–456, 1988PubMedCrossRefGoogle Scholar
  64. Fox PL, Salvatore MF. Serum factor that blocks the action of fish oils on endothelial cell production of platelet-derived growth factor is ceruloplasmin. Laboratory Investigation 66: 467–473, 1992PubMedGoogle Scholar
  65. Franceschini G, Calabresi L, Maderna P, et al. ω3 Fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers. Metabolism 40: 1283–1286, 1991PubMedCrossRefGoogle Scholar
  66. Friday KE, Childs MT, Tsunehara CH, et al. Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes. Diabetes Care 12: 276–281, 1989PubMedCrossRefGoogle Scholar
  67. Friday KE, Failor RA, Childs MT, et al. Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia. Arteriosclerosis and Thrombosis 11: 47–54, 1991PubMedCrossRefGoogle Scholar
  68. Fumeron F, Brigant L, Ollivier V, et al. n-3 polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men. American Journal of Clinical Nutrition 54: 118–122, 1991PubMedGoogle Scholar
  69. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. New England Journal of Medicine 326: 242–250, 310–318, 1992PubMedCrossRefGoogle Scholar
  70. Gans ROB, Bilo HJG, Weersink EGL, et al. Fish oil supplementation in patients with stable claudication. American Journal of Surgery 160: 490–495, 1990PubMedCrossRefGoogle Scholar
  71. Gerasimova E, Perova N, Ozerova I, et al. The effect of dietary n-3 polyunsaturated fatty acids on HDL cholesterol in Chukot residents vs Muscovites. Lipids 4: 261–265, 1991CrossRefGoogle Scholar
  72. Gerdes LU, Schmidt EB, Klausen IC, et al. Plasma concentration levels of apolipoprotein A-I and lipoprotein (a) in Greenland Inuit (Eskimos). Journal of Internal Medicine 231: 623–625, 1992PubMedCrossRefGoogle Scholar
  73. Glauber H, Wallace P, Griver K, et al. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Annals of Internal Medicine 108: 663–668, 1988PubMedGoogle Scholar
  74. Goodnight SH, Harris WS, Connor WE. The effects of dietary ω3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood 58: 880–885, 1981PubMedGoogle Scholar
  75. Gotto Jr AM, LaRosa JC, Hunninghake D, et al. The cholesterol facts. Circulation 81: 1721–1732, 1990PubMedCrossRefGoogle Scholar
  76. Gramenzi A, Gentile A, Fasoli M, et al. Association between certain foods and risk of acute myocardial infarction in women. British Medical Journal 300: 771–773, 1990PubMedCrossRefGoogle Scholar
  77. Grigg LE, Kay TWH, Valentine PA, et al. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. Journal of the American College of Cardiology 13: 665–672, 1989PubMedCrossRefGoogle Scholar
  78. Guichardant M, Traitler H, Spielmann D, et al. Stearidonic acid, an inhibitor of the 5-lipoxygenase pathway: a comparison with timnodonic and dihomogammalinolenic acid. Lipids 28: 321–324, 1993PubMedCrossRefGoogle Scholar
  79. Haines AP, Sanders TAB, Imeson JD, et al. Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics. Thrombosis Research 43: 643–655, 1986PubMedCrossRefGoogle Scholar
  80. Hallaq H, Smith TW, Leaf A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proceedings of the National Academy of Sciences of the United States of America 89: 1760–1764, 1992PubMedCrossRefGoogle Scholar
  81. Hamazaki T, Takazakura E, Osawa K, et al. Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester. Lipids 25: 541–545, 1990PubMedCrossRefGoogle Scholar
  82. Hänninen O, Aagren JJ. Effects of moderate freshwater fish diet on lipid metabolism of Finnish students. Journal of Internal Medicine 225 (Suppl. 1): 77–81, 1989Google Scholar
  83. Hansen J-B, Lyngmo V, Svensson B, et al. Inhibition of exercise-induced shortening of the bleeding time by fish oil in familiar hypercholesterolemia (type IIa). Artersclerosis and Thrombosis 13: 98–104, 1993CrossRefGoogle Scholar
  84. Hansen J-B, Olsen JO, Wilsgård L, et al. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. Journal of Internal Medicine 225 (Suppl. 1): 133–139, 1989Google Scholar
  85. Hansen J-B, Svensson B, Wilsgård L, et al. Serum enriched with n-3 polyunsaturated fatty acids inhibits procoagulant activity in endothelial cells. Blood Coagulation and Fibrinolysis 2: 515–519, 1991PubMedCrossRefGoogle Scholar
  86. Hansen JPH, Hancke S, Møller-Petersen J. Atherosclerosis in native Greenlanders: an ultrasonographic investigation. Arctic Medical Research 49: 151–156, 1990PubMedGoogle Scholar
  87. Hardarson T, Kristinsson A, Skuladottir G, et al. Cod liver oil does not reduce ventricular extrasystoles after myocardial infarction. Journal of Internal Medicine 226: 33–37, 1989PubMedCrossRefGoogle Scholar
  88. Harker LA, Kelly AB, Hanson SR, et al. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 87: 1017–1029, 1993PubMedCrossRefGoogle Scholar
  89. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. Journal of Lipid Research 30: 785–807, 1989PubMedGoogle Scholar
  90. Harris WS, Connor WE, Alam N, et al. Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. Journal of Lipid Research 29: 1451–1460, 1988PubMedGoogle Scholar
  91. Harris WS, Connor WE, Illingworth RD, et al. Effects of fish oil on VLDL triglyceride kinetics in humans. Journal of Lipid Research 31: 1549–1558, 1990aPubMedGoogle Scholar
  92. Harris WS, Muzio F. Fish oil reduced postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. American Journal of Clinical Nutrition 58: 68–74, 1993PubMedGoogle Scholar
  93. Harris WS, Rothrock DW, Fanning A, et al. Fish oils in hypertriglyceridemia: a dose-response study. American Journal of Clinical Nutrition 51: 399–406, 1990cPubMedGoogle Scholar
  94. Harris WS, Silveira S, Dujovne CA. The combined effects of n-3 fatty acids and aspirin on hemostatic parameters in man. Thrombosis Research 57: 517–526, 1990bPubMedCrossRefGoogle Scholar
  95. Harris WS, Windsor SL. n-3 fatty acid supplements reduce chylomicron levels in heathy volunteers. Journal of Applied Nutrition 43: 5–15, 1991Google Scholar
  96. Harvald B. Genetic epidemiology of Greenland. Clinical Genetics 36: 364–367, 1989PubMedCrossRefGoogle Scholar
  97. Hay CRM, Saynor R, Durber AP. Effect of fish oil on platelet kinetics in patients with ischaemic heart disease. Lancet 1: 1269–1272, 1982PubMedCrossRefGoogle Scholar
  98. Hendra TJ, Britton ME, Roper DR, et al. Effects of fish oil supplements in NIDDM subjects. Diabetes Care 13: 821–829, 1990PubMedCrossRefGoogle Scholar
  99. Hepburn FH, Exler J, Weihrauch JL. Provisional tables on the content of omega-3 fatty acids and other fat components of selected foods. Journal of the American Dietary Association 86: 788–793, 1986Google Scholar
  100. Hirai A, Terano T, Tamura Y, et al. Eicosapentaenoic acid and adult diseases in Japan: epidemiological and clinical aspects. Journal of Internal Medicine 225 (Suppl. 1): 69–75, 1989Google Scholar
  101. Hock CE, Beck LD, Bodine RC, et al. Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion. American Journal of Physiology 259: H1518–H1526, 1990PubMedGoogle Scholar
  102. Hock CE, Holahan MA, Reibel DK. Effect of dietary fish oil on myocardial phospholipids and myocardial ischemic damage. American Journal of Physiology 252: H554–H560, 1987PubMedGoogle Scholar
  103. Hornstra G. The significance of fish and fish-oil enriched food for prevention and therapy of cardiovascular disease. In Vergroesen et al. (Eds) The role of fats in human nutrition, pp. 152–335, Academic Press, London, 1989Google Scholar
  104. Hornstra G. The effect of n-3 fatty acids on blood coagulation. In Caterina et al. (Eds) Fish oil and vascular disease, pp. 65–72, Springer-Verlag, Berlin, 1992Google Scholar
  105. Hughes GS, Ringer TV, Watts KC, et al. Fish oil produces an atherogenic lipid profile in hypertensive men. Atherosclerosis 84: 229–237, 1990PubMedCrossRefGoogle Scholar
  106. Hui R, Robillard M, Falardeau P. Inhibition of vasopressin-induced formation of diradylglycerols in vascular smooth muscle cells by incorporation of eicosapentaenoic acid in membrane phospholipids. Journal of Hypertension 10: 1145–1153, 1992PubMedCrossRefGoogle Scholar
  107. Hunter DJ, Kazda I, Chockalingam A, et al. Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison. American Journal of Preventive Medicine 4: 5–10, 1988PubMedGoogle Scholar
  108. Iacoviello L, Amore C, De Curtis A, et al. Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids. Arteriosclerosis and Thrombosis 12: 1191–1197, 1992PubMedCrossRefGoogle Scholar
  109. Illingworth DR, Connor WE, Hatcher LF, et al. Hypolipidaemic effects of n-3 fatty acids in primary hyperlipoproteinaemia. Journal of Internal Medicine 225 (Suppl. 1): 91–97, 1989Google Scholar
  110. Ingeman-Nielsen MW. Arteriosklerose hos grønlændere. Ugeskrift for Laeger 152: 2641–2643, 1990PubMedGoogle Scholar
  111. Islin H, Capito K, Hansen SE, et al. Ability of omega-3 fatty acids to restore the impaired glucose tolerance in a mouse model for type-2 diabetes: different effects in male and female mice. Acta Physiologica Scandinavica 143: 153–160, 1991PubMedCrossRefGoogle Scholar
  112. Jensen T, Stender S, Goldstein K, et al. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. New England Journal of Medicine 321: 1572–1577, 1989PubMedCrossRefGoogle Scholar
  113. Jespersen J, Munkvad S, Gram JB. The fibrinolysis and coagulation systems in ischaemic heart disease. Danish Medical Bulletin 40: 495–502, 1993PubMedGoogle Scholar
  114. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Archives of Internal Medicine 153: 154–208, 1993CrossRefGoogle Scholar
  115. Jørgensen KA, Nielsen AH, Dyerberg J. Hemostatic factors and renin in Greenland Eskimos on a high eicosapentaenoic acid intake. Acta Medica Scandinavica 219: 473–479, 1986PubMedCrossRefGoogle Scholar
  116. Kagawa Y, Nishizawa M, Suzuki M, et al. Eicosapolyenoic acids of serum lipids of Japanese Islanders with low incidence of cardiovascular diseases. Journal of Nutritional Science and Vitaminology 28: 441–453, 1982PubMedCrossRefGoogle Scholar
  117. Kaminsky WE, Jendraschak E, Kiefl R, et al. Dietary ω-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 81: 1871–1879, 1993Google Scholar
  118. Kasim SE, Stern B, Khilnani S, et al. Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients. Journal of Clinical Endocrinology and Metabolism 67: 1–5, 1988PubMedCrossRefGoogle Scholar
  119. Kenny D, Warltier DC, Pleuss JA, et al. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. American Journal of Cardiology 70: 1347–1352, 1992PubMedCrossRefGoogle Scholar
  120. Kim DN, Schmee J, Lee CS, et al. Comparison of effects of fish oil and corn oil supplements on hyperlipidemic diet induced atherogenesis in swine. Atherosclerosis 89: 191–201, 1991PubMedCrossRefGoogle Scholar
  121. Klausen IC, Gerdes LU, Schmidt EB, et al. Differences in apolipoprotein (a) polymorphism in West Greenland Eskimos and Caucasian Danes. Human Genetics 89: 384–388, 1992PubMedCrossRefGoogle Scholar
  122. Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. New England Journal of Medicine 320: 1037–1043, 1989PubMedCrossRefGoogle Scholar
  123. Knapp HR, Reilly IAG, Alessandrini P, et al. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. New England Journal of Medicine 314: 937–942, 1986PubMedCrossRefGoogle Scholar
  124. Kristensen SD, De Caterina R, Schmidt EB, et al. Fish oil and ischaemic heart disease. British Heart Journal 70: 212–214, 1993PubMedCrossRefGoogle Scholar
  125. Kristensen SD, Schmidt EB, Andersen HR, et al. Fish oil in angina pectoris. Atherosclerosis 64: 13–19, 1987PubMedCrossRefGoogle Scholar
  126. Kristensen SD, Schmidt EB, Dyerberg J. Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. Journal of Internal Medicine 225 (Suppl. 1): 141–150, 1989Google Scholar
  127. Kromann N, Green A. Epidemiological studies in Upernavik district, Greenland. Acta Medica Scandinavica 208: 401–406, 1980PubMedCrossRefGoogle Scholar
  128. Kromhout D, Bosschieter EB, Coulander CDL. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New England Journal of Medicine 312: 1205–1209, 1985PubMedCrossRefGoogle Scholar
  129. Lagarde M, Croset M, Véricel E, et al. Effects of small concentrations of eicosapentaenoic acid on platelets. Journal of Internal Medicine 225 (Suppl. 1): 177–179, 1989Google Scholar
  130. Lam JYT, Badimon JJ, Ellefson RD, et al. Cod liver oil alters platelet-arterial wall response to injury in pigs. Circulation Research 71: 769–775, 1992PubMedCrossRefGoogle Scholar
  131. Landgraf-Leurs MMC, Drummer C, Fröschl H, et al. Pilot study on ω-3 fatty acids in type I diabetes mellitus. Diabetes 39: 369–375, 1990PubMedCrossRefGoogle Scholar
  132. Landmark K, Thaulow E, Hysing J, et al. Effects of fish oil, nifedipne and their combination on blood pressure and lipids in primary hypertension. Journal of Human Hypertension 7: 25–32, 1993PubMedGoogle Scholar
  133. Lands WEM. Biosynthesis of Prostaglandins. Annual Review of Nutrition 11: 41–60, 1991PubMedCrossRefGoogle Scholar
  134. Landymore RW, MacAuley M, Sheridan W, et al. Cumulative experience with eicosapentaenoic acid and other platelet inhibitors for the prevention of intimai hyperplasia in autologous vein grafts. In Lands (Ed.) Proceedings of the AOCS short course on polyunsaturated fatty acids and eicosanoids, pp. 342–345, American Oil Chemists Society, Biloxi, 1987Google Scholar
  135. Lapidus L, Andersson H, Bengtsson C, et al. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. American Journal of Clinical Nutrition 44: 444–448, 1986PubMedGoogle Scholar
  136. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. New England Journal of Medicine 318: 549–557, 1988PubMedCrossRefGoogle Scholar
  137. Lee TH, Hoover RL, Williams JD, et al. Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. New England Journal of Medicine 312: 1217–1224, 1985PubMedCrossRefGoogle Scholar
  138. Lehr H-A, Hübner C, Finckh B, et al. Dietary fish oil reduces leuko-cyte/endothelium interaction following systemic administration of oxidatively modified low density lipoprotein. Circulation 84: 1725–1731, 1991PubMedCrossRefGoogle Scholar
  139. Levinson PD, Iosiphidis AH, Saritelli AL, et al. Effects of n-3 fatty acids in essential hypertension. American Journal of Hypertension 3: 754–760, 1990PubMedGoogle Scholar
  140. Li X, Steiner M. Fish oil: a potent inhibitor of platelet adhesiveness. Blood 76: 938–945, 1990PubMedGoogle Scholar
  141. Li X, Steiner M. Dose response of dietary fish oil supplements on platelet adhesiveness. Arteriosclerosis and Thrombosis 11: 39–46, 1991PubMedCrossRefGoogle Scholar
  142. Linn T, Noke M, Woehrle M, et al. Fish-oil enriched diet and reduction of low-dose streptozocin-induced hyperglycemia. Diabetes 38: 1402–1411, 1989PubMedCrossRefGoogle Scholar
  143. Locher R, Sachinidis A, Brunner C, et al. Intracellular free calcium concentration and thromboxane A2 formation of vascular smooth muscle cells are influenced by fish oil and n-3 eicosapentaenoic acid. Scandinavian Journal of Clinical and Laboratory Investigation 51: 541–547, 1991PubMedCrossRefGoogle Scholar
  144. Lofgren RP, Wilt TJ, Nichol KL, et al. The effect of fish oil supplements on blood pressure. American Journal of Public Health 83: 267–269, 1993PubMedCrossRefGoogle Scholar
  145. Lorenz RL, Spengler U, Fischer S, et al. Platelet function, thromboxane formation and blood pressure control during supplementation of the western diet with cod liver oil. Circulation 67: 504–511, 1983PubMedCrossRefGoogle Scholar
  146. Lowe GDO. Blood viscosity and cardiovascular disease. Thrombosis and Haemostasis 67: 494–498, 1992PubMedGoogle Scholar
  147. Luostarinen R, Boberg M, Saldeen T. Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death. Atherosclerosis 99: 187–193, 1993PubMedCrossRefGoogle Scholar
  148. Luostarinen R, Siegbahn A, Saldeen T. Effect of dietary fish oil supplemented with different doses of vitamin E on neutrophil Chemotaxis in healthy volunteers. Nutrition Research 12: 1419–1430, 1992CrossRefGoogle Scholar
  149. Malasanos TH, Stacpoole PW. Biological effects of co-3 fatty acids in diabetes mellitus. Diabetes Care 14: 1160–1179, 1991PubMedCrossRefGoogle Scholar
  150. Malle E, Sattler W, Prenner E, et al. Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp (a) concentrations. Atherosclerosis 88: 193–201, 1991PubMedCrossRefGoogle Scholar
  151. Marckmann P, Jespersen J, Leth T, et al. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. Journal of Internal Medicine 229: 317–323, 1991PubMedCrossRefGoogle Scholar
  152. Margolin G, Huster G, Glueck CJ, et al. Blood pressure lowering in elderly subjects: a double-blind crossover study of ω-3 and ω-6 fatty acids. American Journal of Clinical Nutrition 53: 562–572, 1991PubMedGoogle Scholar
  153. McLennan PL. Relative effects of dietary saturated, mono-unsaturated, and polyunsaturated fatty acids on cardiac arrhytmias in rats. American Journal of Clinical Nutrition 57: 207–212, 1993PubMedGoogle Scholar
  154. McLennan PL, Bridle TM, Abeywardena MY, et al. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. American Heart Journal 123: 1555–1561, 1992PubMedCrossRefGoogle Scholar
  155. McVeigh GE, Brennan GM, Johnston GD, et al. Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 33–38, 1993PubMedCrossRefGoogle Scholar
  156. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Nortwick Park heart study. Lancet 2: 533–537, 1986PubMedCrossRefGoogle Scholar
  157. Mehta JL, Lopez LM, Lawson D, et al. Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease. American Journal of Medicine 84: 45–52, 1988PubMedCrossRefGoogle Scholar
  158. Meland E, Fugelli P, Lærum E, et al. Effect of fish oil on blood pressure and blood lipids in men with mild to moderate hypertension. Scandinavian Journal of Primary Health Care 7: 131–135, 1989PubMedCrossRefGoogle Scholar
  159. Meydani SN, Lichtenstein AH, Colwell S, et al. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. Journal of Clinical Investigation 92: 105–113, 1993PubMedCrossRefGoogle Scholar
  160. Miller ME, Anagnostou AA, Ley B, et al. Effect of fish oil concentrates on hemorheological and hemostatic aspects of diabetes mellitus: a preliminary study. Thrombosis Research 47: 201–214, 1987PubMedCrossRefGoogle Scholar
  161. Mölgaard J, Schenk HV, Lassvik C, et al. Effect of fish oil treatment on plasma lipoproteins in type III hyperlipoproteinaemia. Atherosclerosis 81: 1–9, 1990PubMedCrossRefGoogle Scholar
  162. Møller JM, Svaneborg N, Lervang H-H, et al. The acute effect of a single very high dose of n-3 fatty acids on coagulation and fibrinolysis. Thrombosis Research 67: 569–577, 1992PubMedCrossRefGoogle Scholar
  163. Mori TA, Vandongen R, Mahanian F, et al. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation. Metabolism 41: 1059–1067, 1992PubMedCrossRefGoogle Scholar
  164. Mori TA, Vandongen R, Masarei JRL. Fish oil-induced changes in apolipoproteins in IDDM subjects. Diabetes Care 13: 725–732, 1990PubMedCrossRefGoogle Scholar
  165. Mori TA, Vandongen R, Masarei JRL, et al. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics. Metabolism 40: 241–246, 1991PubMedCrossRefGoogle Scholar
  166. Morris MC, Manson JE, Rosner B, et al. A prospective study of fish consumption on cardiovascular disease. Abstract. Circulation 86 (Suppl. 1): I–463, 1992Google Scholar
  167. Mouratoff GJ, Scott EM. Diabetes mellitus in eskimos after a decade. Journal of the American Medical Association 226: 1345–1346, 1973PubMedCrossRefGoogle Scholar
  168. Müllertz A, Hølmer G, Grøndahl-Hansen J. Increased concentration of Plasminogen activator inhibitor type-1 plasma after intake of fish oil. Fibrinolysis 4 (Suppl 2): 86–88, 1990Google Scholar
  169. Nestel PJ. Effects of n-3 fatty acids on lipid metabolism. Annual Review of Nutrition 10: 149–167, 1990PubMedCrossRefGoogle Scholar
  170. Nestel PJ, Connor WE, Reardon MF, et al. Suppression by diets rich in fish oil of very low density lipoprotein production in man. Journal of Clinical Investigation 74: 82–89, 1984PubMedCrossRefGoogle Scholar
  171. Newman III WP, Propst MT, Middaugh JP. Atherosclerosis in Alaska natives and non-natives. Lancet 341: 1056–1057, 1993PubMedCrossRefGoogle Scholar
  172. Nilsen DWT, Dalaker K, Nordöy A, et al. Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery. Thrombosis and Haemostasis 66: 195–201, 1991PubMedGoogle Scholar
  173. Nordöy A, Barstad L, Connor WE, et al. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. American Journal of Clinical Nutrition 53: 1185–1190, 1991PubMedGoogle Scholar
  174. Nordöy A, Hatcher LF, Ulimann DL, et al. Individual effects of dietary saturated fatty acids and fish oil on plasma lipids and lipoproteins in normal men. American Journal of Clinical Nutrition 57: 634–639, 1993PubMedGoogle Scholar
  175. Nordöy A, Illingworth DR, Connor WE, et al. Increased activity of factor VII and factor-VII phospholipid complex measured using a normotest system in subjects with hyperlipidemia. Haemostasis 20: 65–72, 1990PubMedGoogle Scholar
  176. Norell SE, Ahlbom A, Feychting M, et al. Fish consumption and mortality from heart disease. British Medical Journal 293: 426, 1986PubMedCrossRefGoogle Scholar
  177. Norris PG, Jones CJH, Weston MJ. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. British Medical Journal 293: 104–105, 1986PubMedCrossRefGoogle Scholar
  178. O’Hara M, Esato K, Harada M, et al. Eicosapentaenoic acid suppresses intimai hyperplasia after expanded polytetrafluorethylene grafting in rabbits fed a high cholesterol diet. Journal of Vascular Surgery 13: 480–486, 1991CrossRefGoogle Scholar
  179. Oskarsson HI, Goodwin J, Gunnar RM, et al. Dietary fish oil supplementation reduces myocardial infarct size in a canine model of ischemia and reperfusion. Journal of the American College of Cardiology 21: 1280–1285, 1993PubMedCrossRefGoogle Scholar
  180. Otsuji S, Shibata N, Hirota H, et al. Highly purified eicosapentaenoic acid attenuates tissue damage in experimental myocardial infarction. Japanese Circulation Journal 57: 335–343, 1993PubMedCrossRefGoogle Scholar
  181. Owens MR, Cave WT. Dietary fish lipids do not diminish platelet adhesion to subendothelium. British Journal of Haematology 75: 82–85, 1990PubMedCrossRefGoogle Scholar
  182. Packard CJ, Munro A, Lorimer AR, et al. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypotriglyceridemic subjects. Journal of Clinical Investigation 74: 2178–2192, 1984PubMedCrossRefGoogle Scholar
  183. Parks JS, Rudel LL. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis 84: 83–94, 1990PubMedCrossRefGoogle Scholar
  184. Passfall J. Philipp T, Woermann F, et al. Different effects of eicosapentaenoic acid and olive oil on blood pressure, intracellular free platelet calcium, and plasma lipids in patients with essential hypertension. Clinical Investigation 71: 628–633, 1993Google Scholar
  185. Phillipson BE, Rothrock DW, Connor WE, et al. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. New England Journal of Medicine 312: 1210–1216, 1985PubMedCrossRefGoogle Scholar
  186. Popp-Snijders C, Schouten JA, Heine RJ, et al. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Research 4: 141–147, 1987PubMedGoogle Scholar
  187. Radack K, Deck C, Huster G. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. Archives of Internal Medicine 151: 1173–1180, 1991PubMedCrossRefGoogle Scholar
  188. Rapp JH, Connor WE, Lin DS, et al. Dietary eicosapenta-enoic acid and docosahexaenoic acid from fish oil. Their incorporation into advanced human atherosclerotic plaques. Arteriosclerosis and Thrombosis 11: 903–911, 1991PubMedCrossRefGoogle Scholar
  189. Reis GJ, Sipperly ME, McCabe CH, et al. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 2: 177–181, 1989PubMedCrossRefGoogle Scholar
  190. Renier G, Skamene E, DeSanctis J, et al. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Arteriosclerosis and Thrombosis 13: 1515–1524, 1993PubMedCrossRefGoogle Scholar
  191. Ricevuti G, Mazzone A, Pasotti D, et al. Role of granulocytes in endothelial injury in coronary heart disease in humans. Atherosclerosis 91: 1–14, 1991PubMedCrossRefGoogle Scholar
  192. Richter WO, Jacob BG, Ritter MM, et al. Treatment of primary chylomicronemia due to familial hypertriglyceridemia by ω-3 fatty acids. Metabolism 41: 1100–1105, 1992PubMedCrossRefGoogle Scholar
  193. Rillaerts EG, Engelmann GJ, Van Camp KM, et al. Effect of omega-3 fatty acids in diet of type I diabetic subjects on lipid values and hemorheological parameters. Diabetes 38: 1412–1416, 1989PubMedCrossRefGoogle Scholar
  194. Rogers KA, Adelstein R. MaxEPA fish oil enhances cholesterol-induced intimai foam cell formation in rabbits. American Journal of Pathology 137: 945–951, 1990PubMedGoogle Scholar
  195. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809, 1993PubMedCrossRefGoogle Scholar
  196. Salvi A, Di Stefano O, Sleiman I, et al. Effects of fish oil on serum lipids and lipoprotein(a) levels in heterozygous familial hypercholesterolemia. Current Therapeutic Research 53: 717–721, 1993CrossRefGoogle Scholar
  197. Sanders TAB, Hinds A. The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. British Journal of Nutrition 68: 163–173, 1992PubMedCrossRefGoogle Scholar
  198. Sanders TAB, Sullivan DR, Reeve J, et al. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 5: 459–465, 1985PubMedCrossRefGoogle Scholar
  199. Sandset PM, Lund H, Norseth J, et al. Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arteriosclerosis and Thrombosis 11: 138–145, 1991PubMedCrossRefGoogle Scholar
  200. Sarris GE, Fann JI, Sokoloff MH, et al. Mechanisms responsible for inhibition of vein-graft arteriosclerosis by fish oil. Circulation 80 (Suppl. I): I–109–I–123, 1989Google Scholar
  201. Sarris GE, Mitchell RS, Billingham ME, et al. Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. Journal of Thoracic and Cardiovascular Surgery 97: 841–855, 1989PubMedGoogle Scholar
  202. Sassen LMA, Hartog JM, Lamers JMJ, et al. Mackerel oil and atherosclerosis in pigs. European Heart Journal 10: 838–846, 1989PubMedGoogle Scholar
  203. Sassen LMA, Lamers JMJ, Sluiter W, et al. Development and regression of atherosclerosis in pigs. Arteriosclerosis and Thrombosis 13: 651–660, 1993PubMedCrossRefGoogle Scholar
  204. Saynor R, Gillott T. Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years. Lipids 27: 533–538, 1992PubMedCrossRefGoogle Scholar
  205. Saynor R, Verel D, Gillott T. The long term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 50: 3–10, 1984PubMedCrossRefGoogle Scholar
  206. Schectman G, Kaul S, Kissebah AH. Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 37: 1567–1573, 1988PubMedCrossRefGoogle Scholar
  207. Schectman G, Kaul S, Kissebah AH. Heterogeneity of low density lipoprotein responses to fish-oil supplementation in hypertriglyceridemic subjects. Arteriosclerosis 9: 345–354, 1989PubMedCrossRefGoogle Scholar
  208. Scheurlen M, Kirchner M, Clemens MR, et al. Fish oil preparations rich in docosahexaenoic acid modify platelet responsiveness to prostaglandin-endoperoxide/thromboxane A2 receptor agonists. Biochemical Pharmacology 46: 245–249, 1993PubMedCrossRefGoogle Scholar
  209. Schmidt EB. n-3 fatty acids and fibrinolysis. In De Caterina et al. (Eds) Fish oil and vascular disease, pp. 73–77, Springer-Verlag, Berlin, 1992Google Scholar
  210. Schmidt EB. n-3 polyunsaturated fatty acids and ischaemic heart disease. Current Opinion in Lipidology 4: 27–33, 1993CrossRefGoogle Scholar
  211. Schmidt EB, Klausen IC, Kristensen SD, et al. The effect of n-3 polyunsaturated fatty acids on Lp (a). Clinica Chimica Acta 198: 271–278, 1991aCrossRefGoogle Scholar
  212. Schmidt EB, Kristensen SD, De Caterina R, et al. The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis, in press 103: 107–121, 1993CrossRefGoogle Scholar
  213. Schmidt EB, Kristensen SD, Dyerberg J. The effect of fish oils on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery 15: 316–329, 1988PubMedGoogle Scholar
  214. Schmidt EB, Lervang H-H, Vanning K, et al. Long-term supplementation with n-3 fatty acids. I: effects on blood lipids, hemostasis and blood pressure. Scandinavian Journal of Clinical and Laboratory Investigation 52: 221–228, 1992aPubMedCrossRefGoogle Scholar
  215. Schmidt EB, Møller JM, Svaneborg N, et al. Safety issues of fish oil concentrates: own experience with a reesterified triglyceride preparation (Pikasol*) and a review of the literature. Drug Investigation, in press, 1994Google Scholar
  216. Schmidt EB, Pedersen JO, Ekelund SE, et al. Cod liver oil inhibits neutrophil and monocyte Chemotaxis in healthy males. Atherosclerosis 77: 53–57, 1989bPubMedCrossRefGoogle Scholar
  217. Schmidt EB, Pedersen JO, Vanning K, et al. n-3 fatty acids and leukocyte Chemotaxis: effects in hyperlipidemia and dose-response studies in healthy men. Arteriosclerosis and Thrombosis 11: 429–435, 1991bPubMedCrossRefGoogle Scholar
  218. Schmidt EB, Sørensen PJ, Ernst E, et al. Studies on coagulation and fibrinolysis in Greenland Eskimos. Thrombosis Research 56: 553–558, 1989aPubMedCrossRefGoogle Scholar
  219. Schmidt EB, Sørensen PJ, Pedersen JO, et al. The effect of n-3 polyunsaturated fatty acids on lipids, haemostasis, neutrophil and monocyte Chemotaxis in insulin-dependent diabetes mellitus. Journal of Internal Medicine 225 (Suppl. 1): 201–206, 1989cGoogle Scholar
  220. Schmidt EB, Vanning K, Ernst E, et al. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and hemostasis. Thrombosis and Haemostasis 63: 1–5, 1990PubMedGoogle Scholar
  221. Schmidt EB, Vanning K, Pedersen JO, et al. Long-term supplementation with n-3 fatty acids, II: effect on neutrophil and monocyte Chemotaxis. Scandinavian Journal of Clinical and Laboratory Investigation 52: 229–236, 1992bPubMedCrossRefGoogle Scholar
  222. Schmidt EB, Vanning K, Svaneborg N, et al. n-3 polyunsaturated fatty acid supplementation (Pikasol*) in men with moderate and severe hyperlipidaemia: a dose-response study. Annals of Nutrition and Metabolism 36: 283–287, 1992cPubMedCrossRefGoogle Scholar
  223. Seidelin KN, Myrup B, Fischer-Hansen B. n-3 fatty acids in adipose tissue and coronary artery disease are inversely related. American Journal of Clinical Nutrition 55: 1117–1119, 1992PubMedGoogle Scholar
  224. Shahar E, Folsom AR, Wu KK, et al. Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. Arteriosclerosis and Thrombosis 13: 1205–1212, 1993PubMedCrossRefGoogle Scholar
  225. Shekelle RB, Missell LV, Paul O, et al. Fish consumption and mortality from coronary heart disease. New England Journal of Medicine 313: 820, 1985CrossRefGoogle Scholar
  226. Silverman DI, Ware JA, Sacks FM, et al. Comparison of the absorption and the effect on platelet function of a single dose of n-3 fatty acids given as fish or fish oil. American Journal of Clinical Nutrition 53: 1165–1170, 1991PubMedGoogle Scholar
  227. Simons LA, Hickie JB, Balasubramaniam S. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Atherosclerosis 54: 75–88, 1985PubMedCrossRefGoogle Scholar
  228. Simonsen T, Vårtun Å, Lyngmo V, et al. Coronary heart disease, serum lipids, platelets and dietary fish in two communities in Northern Norway. Acta Medica Scandinavica 222: 237–245, 1987PubMedCrossRefGoogle Scholar
  229. Singer P. Blood pressure-lowering effect of mackerel diet. Klinische Wochenschrift 68 (Suppl. 20): 40–48, 1990PubMedGoogle Scholar
  230. Singer P, Wirth M, Berger I, et al. Influence on serum lipids, lipoproteins and blood pressure of mackerel and herring diet in patients with type IV and V hyperlipoproteinemia. Atherosclerosis 56: 111–118, 1985PubMedCrossRefGoogle Scholar
  231. Smith DL, Willis AL, Nguyen N, et al. Eskimo plasma constituents, dihomolinolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogens. Lipids 24: 70–75, 1989aPubMedCrossRefGoogle Scholar
  232. Smith P, Arnesen H, Opstad T, et al. Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo. Thrombosis Research 53: 467–474, 1989bPubMedCrossRefGoogle Scholar
  233. Spannagl M, Drummer C, Fröschl H, et al. Plasmatic factors of haemostasis remain essentially unchanged except for PAI activity during n-3 fatty acid intake in type I diabetes mellitus. Blood Coagulation and Fibrinolysis 2: 259–265, 1991PubMedCrossRefGoogle Scholar
  234. Spector AA, Yorek MA. Membrane lipid composition and cellular function. Journal of Lipid Research 26: 1015–1035, 1985PubMedGoogle Scholar
  235. Sperling RI, Robin J-L, Kylander KA, et al. The effects of n-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. Journal of Immunology 139: 4186–4191, 1987Google Scholar
  236. Sperling RJ, Benincaso AI, Knoell CT, et al. Dietary co-3 polyunsaturated fatty acids inhibit phosphoinositide formation and Chemotaxis in neutrophils. Journal of Clinical Investigation 91: 651–660, 1993PubMedCrossRefGoogle Scholar
  237. Stacpoole PW, Alig J, Americanmon L, et al. Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia. Metabolism 38: 946–956, 1989PubMedCrossRefGoogle Scholar
  238. Storlien LH, Jenkins AB, Chisholm DJ, et al. Influence of dietary fat composition on development of insulin resistance in rats. Diabetes 40: 280–289, 1991PubMedCrossRefGoogle Scholar
  239. Storlien LH, Kraegen EW, Chisholm DJ, et al. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237: 885–888, 1987PubMedCrossRefGoogle Scholar
  240. Svaneborg N, Møller JM, Schmidt EB, et al. The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids, in press, 1994Google Scholar
  241. Svensson B-G, Nilsson A, Hansson M, et al. Exposure to dioxins and dibenzofurans through the consumption of fish. New England Journal of Medicine 324: 8–12, 1991PubMedCrossRefGoogle Scholar
  242. Swann PG, Parent CA, Croset M, et al. Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. Journal of Biological Chemistry 265: 21692–21697, 1990PubMedGoogle Scholar
  243. Tamura Y, Hirai A, Terano T, et al. Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid. Japanese Circulation Journal 51: 471–477, 1987PubMedCrossRefGoogle Scholar
  244. Tariq T, Close C, Dodds R, et al. The effect of fish-oil on the remission of type 1 (insulin-dependent) diabetes in newly diagnosed patients. Diabetologia 32: 765, 1989PubMedCrossRefGoogle Scholar
  245. Tatò F, Keller C, Wolfram G. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia. Clinical Investigation 71: 314–318, 1993Google Scholar
  246. Terano T, Hirai A, Hamazaki T, et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 46: 321–331, 1983PubMedCrossRefGoogle Scholar
  247. Hypertension Collaborative Research Group. The effects of non-pharmacologic interventions on blood pressure of persons with high normal levels. Journal of the American Medical Association 267: 1213–1220, 1992CrossRefGoogle Scholar
  248. Thiery J, Seidel D. Fish oil feeding results in an enhancement of cholesterol-induced atherosclerosis in rabbits. Atherosclerosis 63: 53–56, 1987PubMedCrossRefGoogle Scholar
  249. Thorngren M, Gustafson A. Effects of 11-week increase in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet 2: 1190–1193, 1981PubMedCrossRefGoogle Scholar
  250. Ullian ME. Fatty acid inhibition of angiotensin II-stimulated inositol phosphates in smooth muscle cells. American Journal of Physiology 264: H595–603, 1993PubMedGoogle Scholar
  251. van Houwelingen AC, Hornstra G, Kromhout D, et al. Habitual fish consumption, fatty acids of serum phospholipids and platelet function. Atherosclerosis 75: 157–165, 1989PubMedCrossRefGoogle Scholar
  252. Vanhoutte PM, Shimokawa H, Boulanger C. Fish oil and the platelet-blood vessel wall interaction. World Review of Nutrition and Dietetics 66: 233–244, 1991PubMedGoogle Scholar
  253. Vessby B, Boberg M. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. Journal of Internal Medicine 228: 165–171, 1990PubMedCrossRefGoogle Scholar
  254. Vollset SE, Heuch I, Bjelke E. Fish consumption and coronary heart disease. New England Journal of Medicine 313: 820–821, 1985CrossRefGoogle Scholar
  255. von Schacky C, Fischer S, Weber PC. Long-term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. Journal of Clinical Investigation 76: 1626–1631, 1985CrossRefGoogle Scholar
  256. von Schacky C, Kiefl R, Marcus AJ, et al. Dietary n-3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes. Biochimica et Biophysica Acta 1166: 20–24, 1993CrossRefGoogle Scholar
  257. von Schacky C, Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acid in humans. Journal of Clinical Investigation 76: 2446–2450, 1985CrossRefGoogle Scholar
  258. Weiner BH, Ockene IS, Levine PH, et al. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. New England Journal of Medicine 315: 841–846, 1986PubMedCrossRefGoogle Scholar
  259. Weintraub MS, Zechner R, Brown A, et al. Dietary polyunsaturated fats of the ω-6 and ω-3 series reduce postprandial lipoprotein levels. Journal of Clinical Investigation 82: 1884–1893, 1988PubMedCrossRefGoogle Scholar
  260. Westerwald HT, De Graaf JC, van Breugel HHFI, et al. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein (a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 16: 683–688, 1993CrossRefGoogle Scholar
  261. Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. New England Journal of Medicine 327: 175–181, 1992PubMedCrossRefGoogle Scholar
  262. Williams CM, Moore F, Morgan L, et al. Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. British Journal of Nutrition 68: 655–666, 1992PubMedCrossRefGoogle Scholar
  263. Wiman B, Hamsten A. Impaired fibrinolysis and risk of thromboembolism. Progress in Cardiovascular Diseases 34: 179–192, 1991PubMedCrossRefGoogle Scholar
  264. Wing LMH, Nestel PJ, Chalmers JP, et al. Lack of effect of fish oil supplementation on blood pressure in treated hypertensives. Journal of Hypertension 8: 339–343, 1990PubMedCrossRefGoogle Scholar
  265. Winther K, Myrup B, Høj C, et al. Decreased platelet reactivity without change in fibrinolyticactivity after low dosages of fish oil. Angiology 22: 39–44, 1993CrossRefGoogle Scholar
  266. Witzkum JL, Steinberg D. Role of oxidised low density lipoprotein in atherogenesis. Journal of Clinical Investigation 88: 1785–1792, 1991CrossRefGoogle Scholar
  267. Wood DA, Butler S, Macintyre C, et al. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1: 177–183, 1987PubMedCrossRefGoogle Scholar
  268. Woodcock BE, Smith E, Lambert WH, et al. Beneficial effect offish oil on blood viscosity in peripheral vascular disease. British Medical Journal 288: 592–594, 1984PubMedCrossRefGoogle Scholar
  269. Yerram NR, Spector AA. Effects of omega-3 fatty acids on vascular smooth muscle cells: reduction in arachidonic acid incorporation into inositol phospholipids. Lipids 24: 594–602, 1989PubMedCrossRefGoogle Scholar
  270. Zambon S, Friday KE, Childs MT, et al. Effect of glyburide and ω3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. American Journal of Clinical Nutrition 56: 447–454, 1992PubMedGoogle Scholar
  271. Zhu B-Q, Parmley WW. Modification of experimental and clinical atherosclerosis by dietary fish oil. American Heart Journal 119: 168–178, 1990PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Erik Berg Schmidt
    • 1
  • Jørn Dyerberg
    • 2
  1. 1.Department of Medicine and HematologyAalborg HospitalAalborgDenmark
  2. 2.Medi-Lab a.s.CopenhagenDenmark

Personalised recommendations